In addition, RE-IIBP, another short isoform of NSD2 that retains catalytic activity, is upregulate in leukemia patients and contributes to transcriptional repression by promoting H3K27 methylation and histone deacetylation [165]. The gene discussed is NSD2; the disease is leukemia.